02218nam 2200601 a 450 991045600540332120200520144314.01-280-19299-297866101929910-309-58791-30-585-02541-X(CKB)110986584751598(SSID)ssj0000137964(PQKBManifestationID)11146785(PQKBTitleCode)TC0000137964(PQKBWorkID)10096668(PQKB)10945348(MiAaPQ)EBC3376237(Au-PeEL)EBL3376237(CaPaEBR)ebr10055260(OCoLC)923262252(EXLCZ)9911098658475159819950206d1995 uy 0engurcn|||||||||txtccrDevelopment of medications for the treatment of opiate and cocaine addictions[electronic resource] issues for the government and private sector /Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of MedicineWashington, DC National Academy Press1995xvii, 250 p. illCommittee chairman: Laurence E. Earley.Support for this study was provided by the National Institute on Drug Abuse.0-309-05244-0 Includes bibliographical references.Drug addictionTreatmentCocaine abuseTreatmentSubstance abuseTreatmentElectronic books.Drug addictionTreatment.Cocaine abuseTreatment.Substance abuseTreatment.616.86/32061Fulco Carolyn905903Liverman Catharyn T879608Earley Laurence E899733MiAaPQMiAaPQMiAaPQBOOK9910456005403321Development of medications for the treatment of opiate and cocaine addictions2243234UNINA